Confirmed NYT that Health & Human Services Department has directed Johnson & Johnson to take over Baltimore Emergent plant for foreseeable future to primarily make just J&J vaccines, not AstraZeneca. This comes after quality control issues ruined up to 15 mil potential J&J doses.

— Kaitlan Collins (@kaitlancollins) April 4, 2021